Literature DB >> 10655474

Optimization of the helper-dependent adenovirus system for production and potency in vivo.

V Sandig1, R Youil, A J Bett, L L Franlin, M Oshima, D Maione, F Wang, M L Metzker, R Savino, C T Caskey.   

Abstract

Helper-dependent (HD) adenoviral vectors devoid of all viral coding sequences provide for safe and highly efficient gene transfer with long-lasting transgene expression. High titer stocks of HD vectors can be generated by using the cre-recombinase system. However, we have encountered difficulties with this system, including rearranged HD vectors and variable efficiency of HD vector rescue. These problems represent a major hindrance, particularly with regard to large-scale production. To overcome these limitations, we have modified the system in two ways: We constructed a new helper virus with a modified packaging signal and enhanced growth characteristics. We also redesigned the vector backbones by including noncoding adenovirus sequences adjacent to the right inverted terminal repeat and by incorporated a number of different segments of noncoding DNA of human origin as "stuffer." Comparison of these vectors showed that the nature of the stuffer sequence affects replication of the HD vector. Optimization of the system resulted in a more robust and consistent production of HD vectors with low helper contamination and high in vivo potency.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10655474      PMCID: PMC15501          DOI: 10.1073/pnas.97.3.1002

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.

Authors:  G Schiedner; N Morral; R J Parks; Y Wu; S C Koopmans; C Langston; F L Graham; A L Beaudet; S Kochanek
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

2.  Complementation of helper-dependent adenoviral vectors: size effects and titer fluctuations.

Authors:  R Alemany; Y Dai; Y C Lou; E Sethi; E Prokopenko; S F Josephs; W W Zhang
Journal:  J Virol Methods       Date:  1997-11       Impact factor: 2.014

3.  Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins.

Authors:  T J Wickham; E Tzeng; L L Shears; P W Roelvink; Y Li; G M Lee; D E Brough; A Lizonova; I Kovesdi
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Role of preterminal protein processing in adenovirus replication.

Authors:  A Webster; I R Leith; J Nicholson; J Hounsell; R T Hay
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

5.  Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses.

Authors:  J F Dedieu; E Vigne; C Torrent; C Jullien; I Mahfouz; J M Caillaud; N Aubailly; C Orsini; J M Guillaume; P Opolon; P Delaere; M Perricaudet; P Yeh
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

6.  Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre.

Authors:  L Chen; M Anton; F L Graham
Journal:  Somat Cell Mol Genet       Date:  1996-11

7.  In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.

Authors:  M Lusky; M Christ; K Rittner; A Dieterle; D Dreyer; B Mourot; H Schultz; F Stoeckel; A Pavirani; M Mehtali
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

8.  Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing alpha1-antitrypsin after systemic delivery.

Authors:  W K O'Neal; H Zhou; N Morral; E Aguilar-Cordova; J Pestaner; C Langston; B Mull; Y Wang; A L Beaudet; B Lee
Journal:  Hum Gene Ther       Date:  1998-07-20       Impact factor: 5.695

9.  Cellular components interact with adenovirus type 5 minimal DNA packaging domains.

Authors:  S I Schmid; P Hearing
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene.

Authors:  M A Morsy; M Gu; S Motzel; J Zhao; J Lin; Q Su; H Allen; L Franlin; R J Parks; F L Graham; S Kochanek; A J Bett; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

View more
  61 in total

1.  Chromosomal integration pattern of a helper-dependent minimal adenovirus vector with a selectable marker inserted into a 27.4-kilobase genomic stuffer.

Authors:  M Hillgenberg; H Tönnies; M Strauss
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Cre levels limit packaging signal excision efficiency in the Cre/loxP helper-dependent adenoviral vector system.

Authors:  Philip Ng; Carole Evelegh; Derek Cummings; Frank L Graham
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector.

Authors:  Shuji Kubo; Kohnosuke Mitani
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

4.  An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus.

Authors:  D Maione; C Della Rocca; P Giannetti; R D'Arrigo; L Liberatoscioli; L L Franlin; V Sandig; G Ciliberto; N La Monica; R Savino
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

5.  General strategy for broadening adenovirus tropism.

Authors:  Laura Fontana; Maurizio Nuzzo; Lorena Urbanelli; Paolo Monaci
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 6.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

7.  Minimal cis-acting elements required for adenovirus genome packaging.

Authors:  Philomena Ostapchuk; Patrick Hearing
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

8.  Genome size and structure determine efficiency of postinternalization steps and gene transfer of capsid-modified adenovirus vectors in a cell-type-specific manner.

Authors:  Dmitry M Shayakhmetov; Zong-Yi Li; Anuj Gaggar; Helen Gharwan; Vladimir Ternovoi; Volker Sandig; André Lieber
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Improved animal models for testing gene therapy for atherosclerosis.

Authors:  Liang Du; Jingwan Zhang; Guido R Y De Meyer; Rowan Flynn; David A Dichek
Journal:  Hum Gene Ther Methods       Date:  2014-02-14       Impact factor: 2.396

10.  Overexpression of endothelial nitric oxide synthase improves endothelium-dependent vasodilation in arteries infused with helper-dependent adenovirus.

Authors:  Bo Jiang; Liang Du; Rowan Flynn; Nagadhara Dronadula; Jingwan Zhang; Francis Kim; David Dichek
Journal:  Hum Gene Ther       Date:  2012-09-24       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.